--- title: "PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors | BNTC Stock News" type: "News" locale: "en" url: "https://longbridge.com/en/news/284201759.md" description: "PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors | BNTC Stock News" datetime: "2026-04-27T03:05:46.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284201759.md) - [en](https://longbridge.com/en/news/284201759.md) - [zh-HK](https://longbridge.com/zh-HK/news/284201759.md) --- # PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors | BNTC Stock News PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors | BNTC Stock News ### Related Stocks - [ITCI.US](https://longbridge.com/en/quote/ITCI.US.md) - [PRTC.US](https://longbridge.com/en/quote/PRTC.US.md) - [BNTC.US](https://longbridge.com/en/quote/BNTC.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PRTCY.US](https://longbridge.com/en/quote/PRTCY.US.md) ## Related News & Research - [Coldstream Capital Management Inc. Sells 28,756 Shares of Zoetis Inc. $ZTS](https://longbridge.com/en/news/287877694.md) - [Dyne Therapeutics To Submit BLA To FDA For Z- Rostudirsen](https://longbridge.com/en/news/287734064.md) - [BUZZ-Outlook Therapeutics jumps on plans to resubmit marketing application for eye disease treatment](https://longbridge.com/en/news/287634369.md) - [Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC | NUVL Stock News](https://longbridge.com/en/news/287754781.md) - [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 | ALGS Stock News](https://longbridge.com/en/news/287726278.md)